The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

Ex-FDA chief Robert Califf about HHS Secretary Robert F. Kennedy Jr. — “My primary worry is not the FDA, my worry is the ...

CitiusTech's John Edward discusses how AI can transform healthcare despite imperfect data, exploring Agentic AI, data quality ...

During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences. Luellen shared the company's ambitious mission ...

Shark Tank investor Kevin O’Leary uploaded a video on Instagram on May 13, 2025, where he shared his opinions on US President ...

Q1 2025 Management View Shantanu Gaur, CEO, stated the company "delivered the first quarter in line with expectations, ...

Health systems face an increasingly complex regulatory landscape with evolving rules on price transparency, prior authorization and Medicaid reimbursement, pushing revenue cycle teams to adapt swiftly ...

D Systems reported weak Q1 results, due in large part to poor materials sales to dental aligner customers. Find out why DDD ...

Confirmed overall response rate (cORR) of 35% and median duration of response (mDOR) >5.6 months (not yet reached) observed in OncoSignature-positive (BM+) patients, a majority of whom were refractory ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

Although initially started as a microscope and camera maker 100 years ago, Olympus is now a dedicated medical device company focusing on endoscopic and surgical solutions. We expect Olympus to enjoy ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best pharma stocks to invest in now amid the domestic ...